These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33632387)

  • 1. Raynaud's Phenomenon: A Vascular Acrosyndrome That Requires Long-Term Care.
    Klein-Weigel P; Sander O; Reinhold S; Nielitz J; Steindl J; Richter J
    Dtsch Arztebl Int; 2021 Apr; 118(Forthcoming):273-80. PubMed ID: 33632387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon-an update on diagnosis, classification and management.
    Pauling JD; Hughes M; Pope JE
    Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's phenomenon].
    Sprynger M
    Rev Med Liege; 2004 Jun; 59(6):378-84. PubMed ID: 15346976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office evaluation and treatment of Raynaud's phenomenon.
    Bolster MB; Maricq HR; Leff RL
    Cleve Clin J Med; 1995; 62(1):51-61. PubMed ID: 7859402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raynaud's phenomenon : Practical management for dermatologists].
    Drerup C; Ehrchen J
    Hautarzt; 2019 Feb; 70(2):131-141. PubMed ID: 30671625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible Cerebral Vasoconstriction Syndrome and Raynaud's Phenomenon: Is There a Link between the Pathogeneses of Their Underlying Complex Etiology? A Case Report and Literature Review.
    Alenzi F; D'Cruz DP
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon : Practical management].
    Drerup C; Maier A; Ehrchen J
    Z Rheumatol; 2019 Dec; 78(10):967-978. PubMed ID: 31712897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
    Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's Phenomenon with Focus on Systemic Sclerosis.
    Maciejewska M; Sikora M; Maciejewski C; Alda-Malicka R; Czuwara J; Rudnicka L
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
    Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
    BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.